<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Autologous stem cell transplantation (ASCT) has emerged as a viable option for the treatment of relapsed follicular non-Hodgkin's <z:hpo ids='HP_0002665'>lymphoma</z:hpo> </plain></SENT>
<SENT sid="1" pm="."><plain>We report on the outpatient experience of 60 patients who underwent ASCT for this condition </plain></SENT>
<SENT sid="2" pm="."><plain>The median age was 51 years (30-65) </plain></SENT>
<SENT sid="3" pm="."><plain>Pre-transplantation conditioning regimens consisted of either <z:chebi fb="0" ids="4911">etoposide</z:chebi>/melphalan/TBI, CBV or BEAM </plain></SENT>
<SENT sid="4" pm="."><plain>Patients participated in this transplant program for a median of 20.5 days (14-78), and 58.4% of the total program days were spent in the outpatient setting </plain></SENT>
<SENT sid="5" pm="."><plain>Six patients were well enough to be treated solely as outpatients </plain></SENT>
<SENT sid="6" pm="."><plain>Ninety percent of patients required at least one inpatient admission (median 7 days), and 70% of first inpatient transfers occurred within the first week following transplant and always before day +12 </plain></SENT>
<SENT sid="7" pm="."><plain>There were no predictors for prolonged inpatient stays </plain></SENT>
<SENT sid="8" pm="."><plain>Febrile <z:hpo ids='HP_0001875'>neutropenia</z:hpo> and gastrointestinal toxicity were the main reasons for inpatient transfers </plain></SENT>
<SENT sid="9" pm="."><plain>No outpatient required an urgent admission to the ICU or died in the outpatient setting </plain></SENT>
<SENT sid="10" pm="."><plain>The treatment-related mortality at days 30 and 100 was 0 and 1.7%, respectively </plain></SENT>
<SENT sid="11" pm="."><plain>The overall and progression-free survivals at 5 years were 65.7 and 56.1%, respectively </plain></SENT>
<SENT sid="12" pm="."><plain>Outpatient ASCT with total body irradiation is feasible, safe, and effective for patients with relapsed follicular <z:hpo ids='HP_0002665'>lymphoma</z:hpo> </plain></SENT>
</text></document>